A Phase II feasibility study of oral etoposide given concurrently with radiotherapy followed by dose intensive adjuvant chemotherapy for children with newly diagnosed high-risk medulloblastoma (protocol POG 9631): A report from the Children's Oncology Group

Adam J. Esbenshade, Mehmet Kocak, Linda Hershon, Pierre Rousseau, Jean Claude Decarie, Susan Shaw, Peter Burger, Henry S. Friedman, Amar Gajjar, Albert Moghrabi

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'A Phase II feasibility study of oral etoposide given concurrently with radiotherapy followed by dose intensive adjuvant chemotherapy for children with newly diagnosed high-risk medulloblastoma (protocol POG 9631): A report from the Children's Oncology Group'. Together they form a unique fingerprint.

Medicine & Life Sciences